Skip to main content

Advertisement

SpringerLink
Log in

Lithium-Associated Hyperparathyroidism: Surgical Strategies in the Era of Minimally Invasive Parathyroidectomy

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Lithium remains an effective treatment of bipolar affective disorder. The long-term use of lithium is associated with an alteration in parathyroid function that may culminate in hyperparathyroidism. The long-term effects of lithium use are variable due to its complex effects on calcium homeostasis and bone metabolism, and as a consequence the indications for surgery remain poorly defined. The optimal surgical strategy for lithium-associated hyperparathyroidism in the era of minimally invasive surgery is also the subject of debate. The aim of the present study was to evaluate the variable findings of lithium-associated parathyroid disease.

Methods

A retrospective review was performed of patients undergoing parathyroid surgery presenting with lithium-associated hyperparathyroidism from July 1999 until July 2009 at the university hospital La Timone, Marseille, and from October 2005 to July 2009 at Hammersmith Hospital, Imperial College, London. Fifteen patients underwent surgery for lithium-associated hyperparathyroidism. Clinical data including patient demographics, duration of lithium use, clinical manifestations of hyperparathyroidism, indications for surgery, and biochemical parameters preoperatively and postoperatively were reviewed. Preoperative imaging, the surgical procedure performed, operative findings, and histopathology were also analyzed.

Results

All 15 patients had preoperative imaging: sestamibi scanning showed that 10 patients had localized single-gland disease, 1 had multiple hot spots, and 4 had a negative scan. Ultrasonography demonstrated a single abnormal gland in 8 patients and multiple enlarged glands in 1 patient; the test was negative in 6. As a consequence of concordant preoperative imaging a minimally invasive approach (endoscopic or a focused lateral approach) was adopted in 3 patients. Focused surgery demonstrated an enlarged hyperplastic gland in 3 cases and resulted in normocalcemia in the immediate postoperative period. However, one patient has a serum calcium at the upper limit of normal and elevated parathyroid hormone (PTH) levels, suggestive of possible recurrence of disease at 15 months follow-up. One patient has permanent hypoparathyroidism. In those patients who had open procedures, final histology showed hyperplastic multiglandular disease in 10 patients (83.3%) of patients and single-gland disease in 2 patients (16.7%). None of these patients show evidence of recurrence at follow-up.

Conclusions

Lithium hyperparathyroidism is predominantly a multiglandular disease characterized by asymmetrical hyperplasia that is frequently associated with misleading or discordant localization studies. Bilateral neck exploration is therefore recommended in order to minimize the risk of disease recurrence.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Cade JF (1949) Lithium salts in the treatment of psychotic excitement. Med J Aust 2:349–352

    PubMed  CAS  Google Scholar 

  2. Cade JF (1975) Lithium—when, why and how? Med J Aust 1:684–686

    PubMed  CAS  Google Scholar 

  3. Hundley JC, Woodrum DT, Saunders BD et al (2005) Revisiting lithium-associated hyperparathyroidism in the era of intraoperative parathyroid hormone monitoring. Surgery 138:1027–1031 discussion 1031–1032

    Article  PubMed  Google Scholar 

  4. Carchman E, Ogilvie J, Holst J et al (2008) Appropriate surgical treatment of lithium-associated hyperparathyroidism. World J Surg 32:2195–2199. doi:10.1007/s00268-008-9616-7

    Article  PubMed  Google Scholar 

  5. Bendz H, Sjodin I, Toss G et al (1996) Hyperparathyroidism and long-term lithium therapy—a cross-sectional study and the effect of lithium withdrawal. J Intern Med 240:357–365

    Article  PubMed  CAS  Google Scholar 

  6. Garfinkel PE, Ezrin C, Stancer HC (1973) Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 2(7824):331–332

    Article  PubMed  CAS  Google Scholar 

  7. Livingstone C, Rampes H (2006) Lithium: a review of its metabolic adverse effects. J Psychopharmacol 20:347–355

    Article  PubMed  Google Scholar 

  8. Saxe A, Gibson G, Silveira E (1995) Effects of long-term lithium infusion on normal parathyroid tissue. Surgery 117:577–580

    Article  PubMed  CAS  Google Scholar 

  9. Saxe AW, Gibson G (1991) Lithium increases tritiated thymidine uptake by abnormal human parathyroid tissue. Surgery 110:1067–1076 discussion 1076–1077

    PubMed  CAS  Google Scholar 

  10. Saunders BD, Saunders EF, Gauger PG (2009) Lithium therapy and hyperparathyroidism: an evidence-based assessment. World J Surg 33:2314–2323. doi:10.1007/s00268-009-9942-4

    Article  PubMed  Google Scholar 

  11. Awad SS, Miskulin J, Thompson N (2003) Parathyroid adenomas versus four-gland hyperplasia as the cause of primary hyperparathyroidism in patients with prolonged lithium therapy. World J Surg 27:486–488. doi:10.1007/s00268-002-6824-4

    Article  PubMed  Google Scholar 

  12. Dwight T, Kytola S, Teh BT et al (2002) Genetic analysis of lithium-associated parathyroid tumors. Eur J Endocrinol 146:619–627

    Article  PubMed  CAS  Google Scholar 

  13. Zamani A, Omrani GR, Nasab MM (2009) Lithium’s effect on bone mineral density. Bone 44:331–334

    Article  PubMed  CAS  Google Scholar 

  14. Baran DT, Schwartz MP, Bergfeld MA et al (1978) Lithium inhibition of bone mineralization and osteoid formation. J Clin Invest 61:1691–1696

    Article  PubMed  CAS  Google Scholar 

  15. Misra M, Papakostas GI, Klibanski A (2004) Effects of psychiatric disorders and psychotropic medications on prolactin and bone metabolism. J Clin Psychiatry 65:1607–1618 quiz 590, 760–761

    Article  PubMed  CAS  Google Scholar 

  16. Mak TW, Shek CC, Chow CC et al (1998) Effects of lithium therapy on bone mineral metabolism: a two-year prospective longitudinal study. J Clin Endocrinol Metab 83:3857–3859

    Article  PubMed  CAS  Google Scholar 

  17. Sloand JA, Shelly MA (2006) Normalization of lithium-induced hypercalcemia and hyperparathyroidism with cinacalcet hydrochloride. Am J Kidney Dis 48:832–847

    Article  PubMed  Google Scholar 

  18. Utiger RD (1999) Treatment of primary hyperparathyroidism. N Engl J Med 341:1301–1302

    Article  PubMed  CAS  Google Scholar 

  19. National Institutes of Health (1991) Consensus development conference statement. J Bone Miner Res Suppl 2:S9–S13

    Google Scholar 

  20. Diagnosis, management of asymptomatic primary hyperparathyroidism (1990) National Institutes of Health Consensus Development Conference, October 29–31, 1990. Nat Inst Health 8:1–18

    Google Scholar 

  21. Gregoor PS, de Jong GM (2007) Lithium hypercalcemia, hyperparathyroidism, and cinacalcet. Kidney Int 71:470

    Article  PubMed  Google Scholar 

  22. Szalat A, Mazeh H, Freund HR (2009) Lithium-associated hyperparathyroidism: report of four cases and review of the literature. Eur J Endocrinol 160:317–323

    Article  PubMed  CAS  Google Scholar 

  23. Dalan R, Leow MK, Jong M (2007) Multiple endocrinopathies associated with lithium therapy. Endocr Pract 13:758–763

    PubMed  Google Scholar 

  24. Khandwala HM, Van Uum S (2006) Reversible hypercalcemia and hyperparathyroidism associated with lithium therapy: case report and review of literature. Endocr Pract 12:54–58

    PubMed  Google Scholar 

  25. Lions C, Precloux P, Burckard E et al (2005) Important hypercalcaemia due to hyperparathyroidism induced by lithium. Ann Fr Anesth Reanim 24:270–273 (in French)

    PubMed  CAS  Google Scholar 

  26. Pieri-Balandraud N, Hugueny P, Henry JF et al (2001) Hyperparathyroidism induced by lithium. A new case. Rev Med Interne 22:460–464 (in French)

    Article  PubMed  CAS  Google Scholar 

  27. Laroche M, Lamboley V, Amigues JM et al (1997) Hyperparathyroidism during lithium therapy. Two new cases. Rev Rhum Engl Ed 64:132–134

    PubMed  CAS  Google Scholar 

  28. de Celis G, Fiter M, Latore X et al (2008) Oxyphilic parathyroid adenoma and lithium therapy. Lancet 352:1070

    Article  Google Scholar 

  29. McHenry CR, Rosen IB, Rotstein LE et al (1990) Lithiumogenic disorders of the thyroid and parathyroid glands as surgical disease. Surgery 108:1001–1005

    PubMed  CAS  Google Scholar 

  30. Abdullah H, Bliss R, Guinea AI et al (1999) Pathology and outcome of surgical treatment for lithium-associated hyperparathyroidism. Br J Surg 86:91–93

    Article  PubMed  CAS  Google Scholar 

  31. Nordenstrom J, Strigard K, Perbeck L et al (1992) Hyperparathyroidism associated with treatment of manic-depressive disorders by lithium. Eur J Surg 158:207–211

    PubMed  CAS  Google Scholar 

  32. Jarhult J, Ander S, Asking B et al (2010) Long-term results of surgery for lithium-associated hyperparathyroidism. Br J Surg 97:1680–1685

    Article  PubMed  CAS  Google Scholar 

  33. Weber KJ, Misra S, Lee JK, Wilhelm SW, DeCresce R, Prinz RA (2004) Intraoperative PTH monitoring in parathyroid hyperplasia requires stricter criteria for success. Surgery 136(6):1154–1159

    Article  PubMed  Google Scholar 

  34. Sebag F, Hubbard JG, Maweja S et al (2003) Negative preoperative localization studies are highly predictive of multiglandular disease in sporadic primary hyperparathyroidism. Surgery 134:1038–1041 discussion 1041–1042

    Article  PubMed  Google Scholar 

  35. Kirkby-Bott J, Markogiannakis H, Skandarajah A et al (2011) Preoperative vitamin D deficiency predicts postoperative hypocalcemia after total thyroidectomy. World J Surg 35:324–330. doi:10.1007/s00268-010-0872-y

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Statistical support for this study was provided by Alexandra Gorelik, Senior Statistician, Collaborative Centre for Clinical Epidemiology, Biostatistics & Health Services Research, and Melbourne Health Royal Melbourne Hospital. Images were provided by Dr. Alpha Tsui.

Author information

Authors and Affiliations

  1. Hammersmith Hospital, Imperial College Healthcare, Du Cane Road, Shepherd’s Bush, London, W12 0HS, United Kingdom

    Anita R. Skandarajah & F. Fausto Palazzo

  2. University Hôpital La Timone, Marseille, France

    Anita R. Skandarajah & Jean-François Henry

  3. Department of Surgery, The Royal Melbourne Hospital, The University of Melbourne, Parkville, VIC, 3050, Australia

    Anita R. Skandarajah

Authors
  1. Anita R. Skandarajah
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Fausto Palazzo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-François Henry
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anita R. Skandarajah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Skandarajah, A.R., Palazzo, F.F. & Henry, JF. Lithium-Associated Hyperparathyroidism: Surgical Strategies in the Era of Minimally Invasive Parathyroidectomy. World J Surg 35, 2432–2439 (2011). https://doi.org/10.1007/s00268-011-1220-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-011-1220-6

Keywords

Search

Navigation